Cosderma Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 35.44%
- Profit Growth 6350.16%
- Ebitda 180.06%
- Net Worth 226.02%
- Total Assets 48.43%
About Cosderma Pharmaceuticals
Cosderma Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 December 2017 (Seven years and one month 26 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suchita Bastapure, Kanhaiya Lal, Sushil Pandey, and One other member serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2017PTC302541
-
Company No.
302541
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Dec 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Cosderma Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanhaiya Lal
|
Director | 06-Dec-2017 | Current |
|
Suchita Bastapure
|
Director | 06-Dec-2017 | Current |
|
Sushil Pandey
|
Director | 06-Dec-2017 | Current |
|
Amit Pandey
|
Director | 06-Dec-2017 | Current |
Financial Performance of Cosderma Pharmaceuticals.
Cosderma Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 35.44% increase. The company also saw a substantial improvement in profitability, with a 6350.16% increase in profit. The company's net worth Soared by an impressive increase of 226.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosderma Pharmaceuticals?
Unlock access to Cosderma Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Cosderma Infra Private LimitedSuchita Bastapure and Kanhaiya Lal are mutual person
-
Cosderma Aesthetica Private Limited
Suchita Bastapure and Kanhaiya Lal are mutual person
-
Cosderma Cosmoceutical Private Limited
Suchita Bastapure and Kanhaiya Lal are mutual person
-
Cosderma Cosmetology Institute Private Limited
Suchita Bastapure and Kanhaiya Lal are mutual person
-
Cosderma Skin Clinic Limited
Suchita Bastapure and Kanhaiya Lal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cosderma Pharmaceuticals?
Unlock and access historical data on people associated with Cosderma Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosderma Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosderma Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.